Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Nebenberuflich Lehrende/r, Klinik für Urologie
Aktuelle Veranstaltungen
-
2023 SS
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomasIn: Cancer Medicine Jg. 12 (2023) Nr. 7, S. 9041 CA Szarvas - 9054ISSN: 2045-7634Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma : A Combined Cohort Analysis, Systematic Review, and Meta-AnalysisIn: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 9,ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ (Open Access)
-
Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation : A systematic review and meta-analysisIn: Reproductive Biology and Endocrinology Jg. 21 (2023) Nr. 1,ISSN: 1477-7827Online Volltext: dx.doi.org/ (Open Access)
-
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysisIn: Cancer Immunology, Immunotherapy Jg. 72 (2023) Nr. 5, S. 1061 - 1073ISSN: 1432-0851; 0340-7004Online Volltext: dx.doi.org/ (Open Access)
-
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axisIn: Molecular Cancer Jg. 22 (2023) Nr. 1,ISSN: 1476-4598Online Volltext: dx.doi.org/ (Open Access)
-
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genesIn: International Journal of Cancer Jg. 150 (2022) Nr. 5, S. 856 - 867ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patientsIn: International Urology and Nephrology Jg. 54 (2022) Nr. 1, S. 71 - 79ISSN: 1573-2584; 0301-1623Online Volltext: dx.doi.org/ (Open Access)
-
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal TumorIn: Frontiers in Oncology Jg. 12 (2022)ISSN: 2234-943XOnline Volltext: dx.doi.org/ (Open Access)
-
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric strictureIn: Langenbeck's Archives of Surgery Jg. 407 (2022) Nr. 3, S. 1233 - 1240ISSN: 1435-2451; 1435-2443; 0023-8236Online Volltext: dx.doi.org/ (Open Access)
-
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancerIn: Journal of Cellular and Molecular Medicine Jg. 26 (2022) Nr. 4, S. 1332 - 1337ISSN: 1582-1838; 1582-4934Online Volltext: dx.doi.org/ (Open Access)
-
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines Jg. 10 (2022) Nr. 3,ISSN: 2227-9059Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for SurvivalIn: Cancers Jg. 14 (2022) Nr. 19,ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial CarcinomaIn: Biomedicines Jg. 10 (2022) Nr. 10,ISSN: 2227-9059Online Volltext: dx.doi.org/ (Open Access)
-
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerIn: Cancer Medicine (2022)ISSN: 2045-7634Online Volltext: dx.doi.org/ (Open Access)
-
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder CancerIn: Genes Jg. 13 (2022) Nr. 3,ISSN: 2073-4425Online Volltext: dx.doi.org/ (Open Access)
-
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancerIn: International Journal of Cancer Jg. 151 (2022) Nr. 8, S. 1405 - 1419ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre CohortIn: Urologia Internationalis Jg. 106 (2022) S. 638 - 643ISSN: 0042-1138; 1423-0399Online Volltext: dx.doi.org/ (Open Access)
-
The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder CancerIn: Current Molecular Medicine Jg. 22 (2022) Nr. 10, S. 941 - 949ISSN: 1875-5666; 1566-5240Online Volltext: dx.doi.org/
-
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients : A systematic review and meta-analysisIn: Prostate Cancer and Prostatic Diseases (2022) in pressISSN: 1365-7852; 1476-5608Online Volltext: dx.doi.org/ (Open Access)
-
A new technological approach in diagnostic pathology : Mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation Jg. 101 (2021) Nr. 9, S. 1281 - 1288ISSN: 0023-6837; 1530-0307Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancerIn: BJU International (BJUI) Jg. 127 (2021) Nr. 1, S. 44 - 55ISSN: 1464-410X; 1464-4096Online Volltext: dx.doi.org/
-
Correction to: : A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation (2021)ISSN: 1530-0307; 0023-6837Online Volltext: dx.doi.org/ (Open Access)
-
Enzalutamide enhances psma expression of psma-low prostate cancerIn: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14,ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 385 - 389ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access)
-
High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapyIn: Cancers Jg. 13 (2021) Nr. 11,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separationIn: Analytica chimica acta Jg. 1184 (2021)ISSN: 1873-4324; 0003-2670Online Volltext: dx.doi.org/ (Open Access)
-
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsIn: Diagnostics Jg. 11 (2021) Nr. 1,ISSN: 2075-4418Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancerIn: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 10, S. 728.e13 - 728.e24ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/ (Open Access)
-
Molecular characterization of muellerian tumors of the urinary tractIn: Genes Jg. 12 (2021) Nr. 6,ISSN: 2073-4425Online Volltext: dx.doi.org/ (Open Access)
-
Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and SurvivalIn: Advances in Therapy (2021)ISSN: 1865-8652; 0741-238XOnline Volltext: dx.doi.org/ (Open Access)
-
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985ISSN: 2223-4691; 2223-4683Online Volltext: dx.doi.org/ (Open Access)
-
Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy : A Multicenter Matched-pair AnalysisIn: European Urology Focus Jg. 7 (2021) Nr. 6, S. 1363 - 1370ISSN: 2405-4569Online Volltext: dx.doi.org/
-
Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patientsIn: Translational Andrology and Urology Jg. 10 (2021) Nr. 1, S. 87 - 95ISSN: 2223-4691; 2223-4683Online Volltext: dx.doi.org/ (Open Access)
-
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapyIn: Urologic Oncology: Seminars and Original Investigations Jg. 39 (2021) Nr. 5, S. 296.e11 - 296.e19ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/ (Open Access)
-
Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor : A hospital-based cancer registry data in JapanIn: International Journal of Urology Jg. 27 (2020) Nr. 2, S. 163 - 164ISSN: 1442-2042; 0919-8172Online Volltext: dx.doi.org/
-
Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cellsIn: Cytometry Part B: Clinical Cytometry Jg. 98 (2020) Nr. 4, S. 355 - 367ISSN: 1552-4957; 1552-4949Online Volltext: dx.doi.org/ (Open Access)
-
Nuclear Localization of Robo is Associated with Better Survival in Bladder CancerIn: Pathology & Oncology Research Jg. 26 (2020) Nr. 1, S. 253 - 261ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/
-
Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancerIn: Cancers Jg. 12 (2020) Nr. 2, S. 353ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prevalence of APC and PTEN Alterations in Urachal CancerIn: Pathology & Oncology Research Jg. 26 (2020) Nr. 4, S. 2773 - 2781ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/ (Open Access)
-
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer PatientsIn: Pathology & Oncology Research Jg. 26 (2020) Nr. 2, S. 1243 - 1249ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/
-
Serum and tissue syndecan-1 levels in renal cell carcinomaIn: Translational Andrology and Urology Jg. 9 (2020) Nr. 3, S. 1167 - 1176ISSN: 2223-4683; 2223-4691Online Volltext: dx.doi.org/
-
Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patientsIn: Diagnostics Jg. 10 (2020) Nr. 11,ISSN: 2075-4418Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Syndecan-1 promotes hepatocyte-like differentiation of hepatoma cells targeting ETS-1 and AP-1In: Biomolecules Jg. 10 (2020) Nr. 10,ISSN: 2218-273XOnline Volltext: dx.doi.org/ (Open Access)
-
Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison studyIn: Urologia Internationalis Jg. 104 (2020) Nr. 9-10, S. 803 - 809ISSN: 0042-1138; 1423-0399Online Volltext: dx.doi.org/
-
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinomaIn: International Journal of Cancer Jg. 145 (2019) Nr. 2, S. 531 - 539ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick BloodIn: Advances in Therapy Jg. 36 (2019) Nr. 4, S. 916 - 922ISSN: 1865-8652; 0741-238XOnline Volltext: dx.doi.org/
-
Das Urachuskarzinom : Ein Update aktueller molekularer ErgebnisseIn: Der Pathologe Jg. 40 (2019) Nr. Suppl. 3, S. 239 - 243ISSN: 0172-8113Online Volltext: dx.doi.org/
-
High soluble CGA levels are associated with poor survival in bladder cancerIn: Endocrine Connections Jg. 8 (2019) Nr. 5, S. 625 - 633ISSN: 2049-3614Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?In: Translational Cancer Research Jg. 8 (2019) Nr. Suppl. 2, S. 176 - S179ISSN: 2219-6803; 2219-6803Online Volltext: dx.doi.org/
-
Prädiktive Biomarker in der onkologischen UropathologieIn: Der Pathologe Jg. 40 (2019) Nr. 3, S. 264 - 275ISSN: 0172-8113; 1432-1963Online Volltext: dx.doi.org/
-
Therapieprädiktive Biomarker des HarnblasenkarzinomsIn: Der Pathologe Jg. 40 (2019) Nr. Suppl. 3, S. 331 - 338ISSN: 0172-8113Online Volltext: dx.doi.org/
-
Urachal cancer : current concepts of a rare cancerIn: Der Pathologe Jg. 40 (2019) Nr. Suppl. 1, S. 31 - 39ISSN: 0172-8113; 1432-1963Online Volltext: dx.doi.org/
-
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations Jg. 37 (2019) Nr. 11, S. 810.e7 - 810.e15ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/
-
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own DataIn: Disease Markers (2018) S. 7308168ISSN: 1875-8630Online Volltext: dx.doi.org/ (Open Access)
-
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancerIn: Urologic Oncology: Seminars and Original Investigations Jg. 36 (2018) Nr. 6, S. 312.e9 - 312.e15ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Das Urachuskarzinom : aktuelle Konzepte einer seltenen TumorerkrankungIn: Der Pathologe Jg. 39 (2018) Nr. Supplement 2, S. 291 - 300ISSN: 0172-8113Online Volltext: dx.doi.org/
-
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancerIn: BJU International Jg. 122 (2018) Nr. 4, S. 695 - 704ISSN: 1464-410X; 1464-4096Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomasIn: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerIn: Urologia Internationalis Jg. 101 (2018) Nr. 1, S. 65 - 73ISSN: 0042-1138; 1423-0399Online Volltext: dx.doi.org/
-
Clinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis PatientsIn: Peritoneal Dialysis International Jg. 37 (2017) Nr. 1, S. 63 - 69ISSN: 0896-8608; 1718-4304Online Volltext: dx.doi.org/
-
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinomaIn: PLoS ONE Jg. 12 (2017) Nr. 4, S. e0176287ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth FactorIn: Pathology & Oncology Research Jg. 23 (2017) Nr. 2, S. 287 - 294ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/
-
Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinomaIn: Pathology Jg. 49 (2017) Nr. 5, S. 561 - 562ISSN: 0031-3025; 1465-3931Online Volltext: dx.doi.org/
-
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific SurvivalIn: Pathology and Oncology Research Jg. 23 (2017) Nr. 3, S. 643 - 650ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/
-
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerIn: Pathology International Jg. 67 (2017) Nr. 12, S. 597 - 601ISSN: 1320-5463; 1440-1827Online Volltext: dx.doi.org/
-
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerIn: The Journal of Urology Jg. 195 (2016) Nr. 4, S. 1120 - 1125ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/
-
Clinical Sequencing-guided Therapy of Urachal Carcinoma : New Perspective for a Rare CancerIn: European Urology Jg. 70 (2016) Nr. 5, S. 776 - 777ISSN: 0302-2838Online Volltext: dx.doi.org/
-
Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 casesIn: Urologic Oncology: Seminars and Original Investigations Jg. 34 (2016) Nr. 9, S. 388 - 398ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/
-
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma : Occurence and prognostic significanceIn: OncoTarget Jg. 7 (2016) Nr. 26, S. 39293 - 39301ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancerIn: Prostate Jg. 76 (2016) Nr. 11, S. 977 - 985ISSN: 0270-4137Online Volltext: dx.doi.org/
-
The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysisIn: International Urology and Nephrology Jg. 48 (2016) Nr. 7, S. 1171 - 1176ISSN: 1573-2584; 0301-1623Online Volltext: dx.doi.org/
-
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on PrognosisIn: Journal of Urology Jg. 195 (2016) Nr. 6, S. 1690 - 1695ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/
-
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay methodIn: International Urology and Nephrology Jg. 48 (2016) Nr. 3, S. 355 - 361ISSN: 1573-2584; 0301-1623Online Volltext: dx.doi.org/
-
Why are upper tract urothelial carcinoma two different diseases?In: Translational Andrology and Urology Jg. 5 (2016) Nr. 5, S. 636 - 647ISSN: 2223-4683Online Volltext: dx.doi.org/ (Open Access)
-
Current State of ERG as Biomarker in Prostatic AdenocarcinomaIn: Current Cancer Drug Targets Jg. 15 (2015) Nr. 8, S. 643 - 651ISSN: 1568-0096Online Volltext: dx.doi.org/
-
Renal cell carcinoma and tumour thrombus in the inferior vena cava : clinical outcome of 98 consecutive patients and the prognostic value of preoperative parametersIn: World journal of urology Jg. 33 (2015) Nr. 10, S. 1541 - 1552ISSN: 0724-4983Online Volltext: dx.doi.org/
-
Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor SuppressorsIn: Non-Coding RNA Jg. 1 (2015) Nr. 3, S. 266 - 284ISSN: 2311-553XOnline Volltext: dx.doi.org/ (Open Access)
-
Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence : A mini-reviewIn: International Journal of Urology Jg. 21 (2014) Nr. 8, S. 753ISSN: 0919-8172; 1442-2042Online Volltext: dx.doi.org/
-
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancerIn: Human Pathology Jg. 45 (2014) Nr. 4, S. 674 - 682ISSN: 0046-8177Online Volltext: dx.doi.org/
-
Erratum zu : Urothelkarzinom der Harnblase. Organerhaltende TherapiestrategienIn: Der Urologe Jg. 53 (2014) Nr. 12, S. 1832ISSN: 0375-4685; 1433-0563Online Volltext: dx.doi.org/
-
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortIn: Cancer Epidemiology, Biomarkers & Prevention Jg. 23 (2014) Nr. 9, S. 1804 - 1812ISSN: 1538-7755; 1055-9965Online Volltext: dx.doi.org/
-
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortIn: The Journal of Urology Jg. 191 (2014) Nr. Suppl. 4, S. E235ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/
-
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations Jg. 32 (2014) Nr. 5, S. 663 - 669ISSN: 1873-2496; 1078-1439Online Volltext: dx.doi.org/
-
Prognostic value of tissue and circulating levels of IMP3 in prostate cancerIn: International Journal of Cancer Jg. 135 (2014) Nr. 7, S. 1596 - 1604ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Re: Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the BladderIn: Journal of Urology Jg. 192 (2014) Nr. 2, S. 617 - 618ISSN: 1527-3792Online Volltext: dx.doi.org/
-
Urothelkarzinom der Harnblase : Organerhaltende TherapiestrategienIn: Der Urologe Jg. 53 (2014) Nr. 9, S. 1322 - 1328ISSN: 0375-4685; 1433-0563Online Volltext: dx.doi.org/ (Open Access)
-
Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomyIn: International Journal of Urology Jg. 20 (2013) Nr. 9, S. 872ISSN: 0919-8172; 1442-2042Online Volltext: dx.doi.org/
-
Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancerIn: PLoS ONE Jg. 8 (2013) Nr. 11, S. e80084ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
MMP-7-Bestimmung im Urin basierend auf Siliziumchiptechnologie : Eine Möglichkeit zur präoperativen Identifizierung von Lymphknotenmetastasen beim HarnblasenkarzinomIn: Der Urologe Jg. 52 (2013) Nr. 6, S. 853 - 858ISSN: 1433-0563; 1433-0563Online Volltext: dx.doi.org/
-
Testosteronmangel - ein unterschätztes Risiko für Männer? : Prävalenz des HypogonadismusIn: Der Urologe Jg. 52 (2013) Nr. 12, S. 1684 - 1689ISSN: 1433-0563Online Volltext: dx.doi.org/
-
The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladderIn: PLoS ONE Jg. 8 (2013) Nr. 9, S. e75681ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancerIn: Urology Jg. 80 (2012) Nr. 3, S. 737.e13 - 737.e18ISSN: 0090-4295; 1527-9995Online Volltext: dx.doi.org/
-
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerIn: BJU International Jg. 110 (2012) Nr. 6B, S. E308 - E317ISSN: 1464-410X; 1464-4096Online Volltext: dx.doi.org/ (Open Access)
-
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancerIn: International Journal of Cancer Jg. 130 (2012) Nr. 12, S. 2922 - 2929ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Tissue MMP-7 expression predicts survival in bladder cancer patients treated with cisplatin-based chemotherapyIn: Journal of Urology Jg. 187 (2012) Nr. Suppl. 4, S. E575 - E575ISSN: 0022-5347; 1527-3792Online Volltext: dx.doi.org/
-
Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tractIn: Urologia Internationalis Jg. 86 (2011) Nr. 1, S. 36 - 40ISSN: 0042-1138; 1423-0399Online Volltext: dx.doi.org/
-
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomyIn: International Journal of Cancer Jg. 128 (2011) Nr. 6, S. 1486 - 1492ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladderIn: Oncology Letters Jg. 2 (2011) Nr. 6, S. 1149 - 1153ISSN: 1792-1082; 1792-1074Online Volltext: dx.doi.org/ (Open Access)
-
Matrix metalloproteinases and their clinical relevance in urinary bladder cancerIn: Nature Reviews Urology Jg. 8 (2011) Nr. 5, S. 241 - 254ISSN: 1759-4820; 1759-4812Online Volltext: dx.doi.org/
-
Photodynamische Diagnostik des HarnblasenkarzinomsIn: Der Urologe Jg. 50 (2011) Nr. 9, S. 1068 - 1071ISSN: 0375-4685; 1433-0563Online Volltext: dx.doi.org/
-
Plasmakonzentrationen von E-Cadherin bei Tumorerkrankungen der Harnblase : Kann die Prognoseabschätzung hiermit verbessert werden?In: Der Urologe Jg. 50 (2011) Nr. 1, S. 64 - 70ISSN: 1433-0563; 0042-1103; 0340-2592Online Volltext: dx.doi.org/
-
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancerIn: BJU International Jg. 107 (2011) Nr. 7, S. 1069 - 1073ISSN: 1464-410X; 1365-2176; 1464-4096; 0007-1331Online Volltext: dx.doi.org/
-
Urothelkarzinom der Harnblase : Kombinierte endoskopische und urinzytologische Beurteilung: Lässt es sich sicher einschätzen?In: Der Urologe Jg. 50 (2011) Nr. 6, S. 702 - 705ISSN: 1433-0563; 0340-2592; 0042-1103Online Volltext: dx.doi.org/
-
Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder CancerIn: Pathology & Oncology Research Jg. 17 (2011) Nr. 2, S. 325 - 332ISSN: 1532-2807; 1219-4956Online Volltext: dx.doi.org/
-
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancerIn: Cancer Science Jg. 101 (2010) Nr. 5, S. 1300 - 1308ISSN: 1349-7006; 1344-6428; 0910-5050; 1347-9032Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancerIn: Cancer Jg. 116 (2010) Nr. 19, S. 4502 - 4512ISSN: 1097-0142; 0008-543XOnline Volltext: dx.doi.org/
-
The prognostic value of cadherin switch in bladder cancerIn: Oncology Reports Jg. 23 (2010) Nr. 4, S. 1125 - 1132ISSN: 1791-2431; 1021-335X
-
Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancerIn: Clinical Cancer Research Jg. 14 (2008) Nr. 24, S. 8253 - 8262ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/ (Open Access)
-
Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim HarnblasenkarzinomIn: Urologe - Ausgabe A Jg. 46 (2007) Nr. 9, S. 1152 - 1156ISSN: 0340-2592; 1433-0563Online Volltext: dx.doi.org/
-
Correction to : COVID-19 research ; promising tracks leading to uro-oncologyIn: International Urology and Nephrology Jg. 53 (2021) Nr. 1, S. 95ISSN: 1573-2584; 0301-1623Online Volltext: dx.doi.org/ (Open Access)
-
COVID-19 research : promising tracks leading to uro-oncologyIn: International Urology and Nephrology Jg. 52 (2020) Nr. 6, S. 995 - 997ISSN: 1573-2584; 0301-1623Online Volltext: dx.doi.org/ (Open Access)
-
Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378ISSN: 0893-3952; 1530-0285Online Volltext: dx.doi.org/ (Open Access) -
Expression of Receptor of Hyaluronan Mediated Motility (RHAMM) is associated with progression of bladder cancer and poor prognosis
77th Annual Meeting, March 30 – April 1, 2011, Frankfurt a. M., Germany,In: Naunyn-Schmiedeberg's Archives of Pharmacology Jg. 383 (2011) Nr. Suppl. 1, S. 69 - 70ISSN: 0028-1298; 1432-1912Online Volltext: dx.doi.org/ -
Bedeutung molekularer Mechanismen bei der prognostischen Abschätzung urologischer TumorerkrankungenDuisburg, Essen (2011) CD-ROM